@anagabrielacf.bsky.social
Reposted
Nice blog post about the various milk options and what they offer kidney patients:
www.medscape.com/viewarticle/...
www.medscape.com/viewarticle/...
Got Milk? It’s a Tricky Question for Renal Patients
Renal diets with limits on protein, potassium, phosphorus, calcium, and sodium make milk choices baffling. Knowing the pros and cons of a variety of milks can help take the guesswork out of breakfast.
www.medscape.com
December 23, 2025 at 2:11 PM
Nice blog post about the various milk options and what they offer kidney patients:
www.medscape.com/viewarticle/...
www.medscape.com/viewarticle/...
Reposted
👉🏻 The Dawn of the ASIs
👀 Baxdrostat shows:
🩺 ↓ SBP ~25 mmHg
⚡ Normalization of K
📉 97% reduction in aldosterone
A clear “win” so far, let’s see what the ongoing phase 3 trial reveals 👀
#NephJC #NephSky #MedSky
👀 Baxdrostat shows:
🩺 ↓ SBP ~25 mmHg
⚡ Normalization of K
📉 97% reduction in aldosterone
A clear “win” so far, let’s see what the ongoing phase 3 trial reveals 👀
#NephJC #NephSky #MedSky
Our take on the baxdrostat PA trial in @asnpublications.bsky.social #KidneyNews
www.kidneynews.org/view/journal... with @nephroseeker.medsky.social and @dramiliflores.bsky.social !
Thanks to Sam Kant and @kdjhaveri.bsky.social for the invite!!
www.kidneynews.org/view/journal... with @nephroseeker.medsky.social and @dramiliflores.bsky.social !
Thanks to Sam Kant and @kdjhaveri.bsky.social for the invite!!
December 9, 2025 at 3:26 PM
Reposted
Examples of common IV antibiotics and their sodium content:
- Ampicillin: 731 mg/dose → 2,924 mg/day
- Ceftriaxone: 55 mg/dose → 110 mg/day
- Metronidazole: 324 mg/dose → 973 mg/day
- Piperacillin-Tazobactam: 556 mg/dose → 1,668 mg/day
- Vancomycin: 885 mg/dose → 1,770 mg/day
- Ampicillin: 731 mg/dose → 2,924 mg/day
- Ceftriaxone: 55 mg/dose → 110 mg/day
- Metronidazole: 324 mg/dose → 973 mg/day
- Piperacillin-Tazobactam: 556 mg/dose → 1,668 mg/day
- Vancomycin: 885 mg/dose → 1,770 mg/day
December 8, 2025 at 9:28 AM
Examples of common IV antibiotics and their sodium content:
- Ampicillin: 731 mg/dose → 2,924 mg/day
- Ceftriaxone: 55 mg/dose → 110 mg/day
- Metronidazole: 324 mg/dose → 973 mg/day
- Piperacillin-Tazobactam: 556 mg/dose → 1,668 mg/day
- Vancomycin: 885 mg/dose → 1,770 mg/day
- Ampicillin: 731 mg/dose → 2,924 mg/day
- Ceftriaxone: 55 mg/dose → 110 mg/day
- Metronidazole: 324 mg/dose → 973 mg/day
- Piperacillin-Tazobactam: 556 mg/dose → 1,668 mg/day
- Vancomycin: 885 mg/dose → 1,770 mg/day
Reposted
Strange papers
Cost-effectiveness analysis in @jama.com JNO
jamanetwork.com/journals/jam...
Seems to suggest standard (versus early) dialysis in AKI is more expensive? (It was still cost effective)
Which is strange considering in STARRTAKI there was *less* dialysis in standard
Cost-effectiveness analysis in @jama.com JNO
jamanetwork.com/journals/jam...
Seems to suggest standard (versus early) dialysis in AKI is more expensive? (It was still cost effective)
Which is strange considering in STARRTAKI there was *less* dialysis in standard
October 3, 2025 at 8:11 PM
Strange papers
Cost-effectiveness analysis in @jama.com JNO
jamanetwork.com/journals/jam...
Seems to suggest standard (versus early) dialysis in AKI is more expensive? (It was still cost effective)
Which is strange considering in STARRTAKI there was *less* dialysis in standard
Cost-effectiveness analysis in @jama.com JNO
jamanetwork.com/journals/jam...
Seems to suggest standard (versus early) dialysis in AKI is more expensive? (It was still cost effective)
Which is strange considering in STARRTAKI there was *less* dialysis in standard
Reposted
Huntington’s disease treated successfully for first time in gene therapy trial
Huntington’s disease treated successfully for first time in gene therapy trial
UCL trialled hours-long surgical procedure to treat disease which causes dementia and paralysis
Huntington’s disease, a devastating degenerative illness that runs in families, has been treated successfully for the first time in a breakthrough gene therapy trial.
The disease, caused by a single gene defect, steadily kills brain cells leading to dementia, paralysis and ultimately death. Those with a parent with Huntington’s have a 50% chance of developing the disease, which until now has been incurable. Continue reading...
www.theguardian.com
September 24, 2025 at 2:05 PM
Huntington’s disease treated successfully for first time in gene therapy trial
Reposted
T1b
BP Measurement: In 2017 ‘proper’ technique was recommended and that has transitioned to standardized technique in 2025. Let’s all use a checklist…and let’s use it every time! How close is your regular practice to this standard?
#NephJC
BP Measurement: In 2017 ‘proper’ technique was recommended and that has transitioned to standardized technique in 2025. Let’s all use a checklist…and let’s use it every time! How close is your regular practice to this standard?
#NephJC
September 17, 2025 at 1:15 AM
T1b
BP Measurement: In 2017 ‘proper’ technique was recommended and that has transitioned to standardized technique in 2025. Let’s all use a checklist…and let’s use it every time! How close is your regular practice to this standard?
#NephJC
BP Measurement: In 2017 ‘proper’ technique was recommended and that has transitioned to standardized technique in 2025. Let’s all use a checklist…and let’s use it every time! How close is your regular practice to this standard?
#NephJC
Reposted
🧮
qxmd.com/calculate/ca...
📚
Cohen, L. M., et al.(2010). Predicting six-month mortality for patients who are on maintenance hemodialysis. Clinical Journal of the American Society of Nephrology, 5(1), 72–79
pubmed.ncbi.nlm.nih.gov/19965531/
qxmd.com/calculate/ca...
📚
Cohen, L. M., et al.(2010). Predicting six-month mortality for patients who are on maintenance hemodialysis. Clinical Journal of the American Society of Nephrology, 5(1), 72–79
pubmed.ncbi.nlm.nih.gov/19965531/
September 10, 2025 at 3:01 AM
🧮
qxmd.com/calculate/ca...
📚
Cohen, L. M., et al.(2010). Predicting six-month mortality for patients who are on maintenance hemodialysis. Clinical Journal of the American Society of Nephrology, 5(1), 72–79
pubmed.ncbi.nlm.nih.gov/19965531/
qxmd.com/calculate/ca...
📚
Cohen, L. M., et al.(2010). Predicting six-month mortality for patients who are on maintenance hemodialysis. Clinical Journal of the American Society of Nephrology, 5(1), 72–79
pubmed.ncbi.nlm.nih.gov/19965531/
Reposted
📚
Tabata, A., et al.(2025). Association between physical function and hospitalization among older patients with pre‐dialysis chronic kidney disease after educational hospitalization: A single‐center prospective cohort study. Therapeutic Apheresis and Dialysis, 29(4), 682–690.
Tabata, A., et al.(2025). Association between physical function and hospitalization among older patients with pre‐dialysis chronic kidney disease after educational hospitalization: A single‐center prospective cohort study. Therapeutic Apheresis and Dialysis, 29(4), 682–690.
August 17, 2025 at 3:44 PM
📚
Tabata, A., et al.(2025). Association between physical function and hospitalization among older patients with pre‐dialysis chronic kidney disease after educational hospitalization: A single‐center prospective cohort study. Therapeutic Apheresis and Dialysis, 29(4), 682–690.
Tabata, A., et al.(2025). Association between physical function and hospitalization among older patients with pre‐dialysis chronic kidney disease after educational hospitalization: A single‐center prospective cohort study. Therapeutic Apheresis and Dialysis, 29(4), 682–690.
Reposted
This month's issue of #ASNKidneyNews features "The Inferno Within," kidney artistry by AnilzArt embodying the slow and smoldering burn of chronic kidney disease through abstract digital art. kidney.pub/KN1707-18 #ASNKidneyNews
August 2, 2025 at 4:00 PM
This month's issue of #ASNKidneyNews features "The Inferno Within," kidney artistry by AnilzArt embodying the slow and smoldering burn of chronic kidney disease through abstract digital art. kidney.pub/KN1707-18 #ASNKidneyNews
Reposted
📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Renal Outcomes Over the Course of 5 Years of Oral HIV Preexposure Prophylaxis Using Tenofovir Disoproxil/Emtricitabine www.kireports.org/ar...
August 1, 2025 at 6:00 AM
📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Renal Outcomes Over the Course of 5 Years of Oral HIV Preexposure Prophylaxis Using Tenofovir Disoproxil/Emtricitabine www.kireports.org/ar...
Reposted
📚
Davison, S. N. (2019). Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clinical Journal of the American Society of Nephrology, 14(6), 917–931.
Davison, S. N. (2019). Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clinical Journal of the American Society of Nephrology, 14(6), 917–931.
July 20, 2025 at 10:10 PM
📚
Davison, S. N. (2019). Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clinical Journal of the American Society of Nephrology, 14(6), 917–931.
Davison, S. N. (2019). Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clinical Journal of the American Society of Nephrology, 14(6), 917–931.
Reposted
Patients with kidney failure were less likely to receive endoscopy, revealing a potential care gap. This study in #ASNKidney360 evaluates angiodysplasia-related gastrointestinal bleeding incidence, outcomes, and readmissions among patients with CKD. Read more: kidney.pub/KID0901
July 18, 2025 at 5:00 PM
Patients with kidney failure were less likely to receive endoscopy, revealing a potential care gap. This study in #ASNKidney360 evaluates angiodysplasia-related gastrointestinal bleeding incidence, outcomes, and readmissions among patients with CKD. Read more: kidney.pub/KID0901
Reposted
Design of the CURE study which we hope will disentangle the etiologies and mechanisms of CKDu (beyond mesoamerican nephropathy - there’s one site in India too, though not Sri Lanka ) www.kireports.org/article/S246... in @kireports.bsky.social
#NephSky
#NephSky
June 30, 2025 at 12:31 PM
Design of the CURE study which we hope will disentangle the etiologies and mechanisms of CKDu (beyond mesoamerican nephropathy - there’s one site in India too, though not Sri Lanka ) www.kireports.org/article/S246... in @kireports.bsky.social
#NephSky
#NephSky
Reposted
Peritoneal Dialysis (PD) Catheter INFLOW FAILURE
#Nephpearls #NephSky
✅ Heparinized Saline 20 mL flush
✅ Heparin 500 units/L
✅ KUB
✅ t-PA 2 mgs/ 40 mL NS
#Nephpearls #NephSky
✅ Heparinized Saline 20 mL flush
✅ Heparin 500 units/L
✅ KUB
✅ t-PA 2 mgs/ 40 mL NS
July 12, 2025 at 7:17 PM
Peritoneal Dialysis (PD) Catheter INFLOW FAILURE
#Nephpearls #NephSky
✅ Heparinized Saline 20 mL flush
✅ Heparin 500 units/L
✅ KUB
✅ t-PA 2 mgs/ 40 mL NS
#Nephpearls #NephSky
✅ Heparinized Saline 20 mL flush
✅ Heparin 500 units/L
✅ KUB
✅ t-PA 2 mgs/ 40 mL NS
Reposted
New study in #ASNKidney360 found that kidney transplants can boost patients' physical quality of life over dialysis, but mental health and symptoms like fatigue remain a challenge. kidney.pub/KID0844
July 10, 2025 at 6:00 PM
New study in #ASNKidney360 found that kidney transplants can boost patients' physical quality of life over dialysis, but mental health and symptoms like fatigue remain a challenge. kidney.pub/KID0844
Reposted
Management of the Hemodialysis Patient with Catheter-Related Bloodstream (CRBSI) Infection ca. 2019
#Nephpearls #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/30837242/
#Nephpearls #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/30837242/
July 7, 2025 at 8:36 PM
Management of the Hemodialysis Patient with Catheter-Related Bloodstream (CRBSI) Infection ca. 2019
#Nephpearls #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/30837242/
#Nephpearls #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/30837242/
Reposted
A Systematic #Review of Treatment for Acute #Interstitial #Nephritis #AIN
#VisualAbstract by @krithicism.bsky.social
www.kireports.org/ar...
#VisualAbstract by @krithicism.bsky.social
www.kireports.org/ar...
July 7, 2025 at 3:00 PM
A Systematic #Review of Treatment for Acute #Interstitial #Nephritis #AIN
#VisualAbstract by @krithicism.bsky.social
www.kireports.org/ar...
#VisualAbstract by @krithicism.bsky.social
www.kireports.org/ar...
Reposted
Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis
doi.org/10.1016/j.kint.2025.06.004
#NephSky #MedSky #hemodialysis
doi.org/10.1016/j.kint.2025.06.004
#NephSky #MedSky #hemodialysis
July 7, 2025 at 3:06 PM
Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis
doi.org/10.1016/j.kint.2025.06.004
#NephSky #MedSky #hemodialysis
doi.org/10.1016/j.kint.2025.06.004
#NephSky #MedSky #hemodialysis
Reposted
An #ASNCJASN study offers an evidence-based definition of proteinuria remission, suitable for patient care and clinical trials. kidney.pub/CJASN0751
July 4, 2025 at 4:46 PM
An #ASNCJASN study offers an evidence-based definition of proteinuria remission, suitable for patient care and clinical trials. kidney.pub/CJASN0751
Reposted
Stopping renin-angiotensin system inhibitors (RASi) within two days of AKI detection was associated with lower risk, adding to evidence about the optimal management of RASi during an episode of AKI. #ASNJASN kidney.pub/JASN0775
July 4, 2025 at 6:00 PM
Stopping renin-angiotensin system inhibitors (RASi) within two days of AKI detection was associated with lower risk, adding to evidence about the optimal management of RASi during an episode of AKI. #ASNJASN kidney.pub/JASN0775
Reposted
📚
Pépin, M., Levassort, H., & Massy, Z. A. (2024). The impact of chronic kidney disease on cognitive function. Current Opinion in Nephrology and Hypertension, 33(6), 566–572
Pépin, M., Levassort, H., & Massy, Z. A. (2024). The impact of chronic kidney disease on cognitive function. Current Opinion in Nephrology and Hypertension, 33(6), 566–572
July 3, 2025 at 8:26 PM
📚
Pépin, M., Levassort, H., & Massy, Z. A. (2024). The impact of chronic kidney disease on cognitive function. Current Opinion in Nephrology and Hypertension, 33(6), 566–572
Pépin, M., Levassort, H., & Massy, Z. A. (2024). The impact of chronic kidney disease on cognitive function. Current Opinion in Nephrology and Hypertension, 33(6), 566–572
Reposted
Exclusive: Towana Looney, a 53-year-old woman who received a kidney from a gene-edited pig on 25 November 2024, had it removed last week after the organ suddenly stopped functioning, Science has learned. scim.ag/3EiaJmM
Longest human transplant of pig kidney fails
In latest xenotransplant test, Towana Looney’s body rejects gene-edited organ after more than 4 months
scim.ag
April 11, 2025 at 12:12 PM
Exclusive: Towana Looney, a 53-year-old woman who received a kidney from a gene-edited pig on 25 November 2024, had it removed last week after the organ suddenly stopped functioning, Science has learned. scim.ag/3EiaJmM
Reposted
In a study of a new ultrafiltration rate feedback controller, results showed that it operated as intended, leading to a substantial increase in relative blood volume target range attainment. kidney.pub/KID0839 #ASNKidney360
June 27, 2025 at 5:00 PM
In a study of a new ultrafiltration rate feedback controller, results showed that it operated as intended, leading to a substantial increase in relative blood volume target range attainment. kidney.pub/KID0839 #ASNKidney360
Reposted
June 17, 2025 at 2:51 PM